Nurix Therapeutics Inc (NRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 05-2021 | 02-2021 | 11-2020 | 08-2020 | 05-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 188,207 | 126,381 | 119,356 | 265,527 | 159,329 |
| Marketable Securities | 197,814 | 176,692 | 161,792 | 88,716 | 14,174 |
| Receivables | 5,679 | 3,981 | 3,846 | 3,856 | 19,590 |
| Other current assets | 0 | 0 | 7,500 | 0 | 0 |
| TOTAL | $396,281 | $310,768 | $298,434 | $364,089 | $196,804 |
| Non-Current Assets | |||||
| PPE Net | 8,345 | 6,960 | 6,672 | 6,532 | 5,789 |
| Investments And Advances | 110,440 | 77,191 | 90,890 | 40,898 | 9,110 |
| Other Non-Current Assets | 2,915 | 1,741 | 347 | 355 | 1,574 |
| TOTAL | $121,700 | $85,892 | $97,909 | $47,785 | $16,473 |
| Total Assets | $517,981 | $396,660 | $396,343 | $411,874 | $213,277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,405 | 4,388 | 3,412 | 3,611 | 4,903 |
| Accrued Expenses | 7,678 | 10,833 | 8,328 | 7,102 | 4,161 |
| TOTAL | $46,844 | $47,972 | $44,539 | $41,012 | $34,436 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 33,761 | 32,751 | 32,799 | 30,299 | 25,372 |
| Other Non-Current Liabilities | 837 | 832 | 850 | 868 | 168,980 |
| TOTAL | $72,959 | $78,555 | $61,535 | $63,242 | $240,367 |
| Total Liabilities | $119,803 | $126,527 | $106,074 | $104,254 | $274,803 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,427 | 44,347 | 38,907 | 38,855 | 37,038 |
| Common Shares | 44 | 39 | 39 | 39 | 4 |
| Retained earnings | -154,355 | -127,973 | -103,698 | -83,784 | -65,267 |
| Other shareholders' equity | 30 | 49 | 87 | 138 | 139 |
| TOTAL | $398,178 | $270,133 | $290,269 | $307,620 | $-61,526 |
| Total Liabilities And Equity | $517,981 | $396,660 | $396,343 | $411,874 | $213,277 |